Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers have used deep learning to assess three key biomarkers of existing breast cancers on routinely acquired histology slides. In the process, the team has advanced AI-based biomarker analysis for managing a range of cancers.
When a black-box algorithm guides a physician’s diagnostic or therapeutic judgments, its intrinsic opaqueness can confound subsequent steps toward clinical safety and efficacy—and that’s just for starters.
An AI tool for managing pediatric asthma shaved 7.8 minutes from the time pediatricians spent dealing with electronic health records in a randomized clinical trial conducted at the Mayo Clinic.
Deep learning can accurately distinguish dementia from mild cognitive impairment by looking at pictures of analog clocks as drawn by individuals thought to be affected.
AI-aimed blasting of kidney stones from outside the body hit intended targets at a 75% clip in a proof-of-concept study, pulverizing conventional lithotripsy, which missed the mark almost half the time.
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.